Anna F.

Anna F. currently serves in the office of the CEO at Retro Biosciences since January 2025. Prior to this role, Anna F. spent over a decade at 23andMe, where positions included Director of Program Management for both Consumer and Research sectors, contributing to the mission of enhancing public accessibility to genomic information. Previously, experience at Genentech involved senior project management focused on oncology biomarker development and biosample operations. Early career roles included management and operational responsibilities at Consumer Genetics Inc. and ClearCount Medical Solutions, as well as research assistant positions at the National Cancer Institute. Anna F. holds a BA in Biological Sciences from Cornell University and an MA in Genetics and Development from Columbia University.